Learn / BLLN
NASDAQ: BLLN
BillionToOne (BLLN) stock, explained like you're 5
BillionToOne trades on the Nasdaq under the ticker BLLN. It is a mid cap company in the medical specialities industry, part of the healthcare sector, with a market value of about 4.6 billion dollars.
- Ticker
- BLLN
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Medical Specialities
- Size
- Mid cap, about 4.6 billion dollars
Is BillionToOne a small, medium or large cap company?
No. BillionToOne is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 4.6 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How BillionToOne makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves BLLN stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- BillionToOne (NasdaqGS:BLLN) Stock Forecast & Analyst Predictions (Simply Wall Street)
- Exercising $2.80 options, BillionToOne (BLLN) CEO Atay also sells shares under a trading plan. (Stock Titan)
- Billiontoone (NASDAQ:BLLN) Stock: Insider Oguzhan Atay Sells 5,150 Shares (MarketBeat)
- BillionToOne (NasdaqGS:BLLN) Stock Fair Value Edges Higher As Analysts Weigh Tech And Reimbursement Risk (Yahoo Finance)
- BillionToOne CEO Oguzhan Atay sells $1.09 million in stock (Investing.com)
Follow BLLN in your daily brief
Each trading day at 5 PM ET we post what happened to BillionToOne and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow BLLN
Questions about BillionToOne stock
What does BillionToOne do?
BillionToOne trades on the Nasdaq under the ticker BLLN. It is a mid cap company in the medical specialities industry, part of the healthcare sector, with a market value of about 4.6 billion dollars.
What is the ticker symbol for BillionToOne?
BillionToOne trades under the ticker BLLN on the Nasdaq.
What is BillionToOne's market cap?
BillionToOne is a mid cap stock with a market cap of about 4.6 billion dollars.
How does BillionToOne make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves BLLN stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow BLLN stock every day?
Add BLLN to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.